Clinical Mechanism of the Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor in G551D-mediated Cystic Fibrosis-Reference-Cited by-同舟云学术

Clinical Mechanism of the Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor in G551D-mediated Cystic Fibrosis

Published:2014-07-15 Issue:2 Volume:190 Page:175-184
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Rowe Steven M.,Heltshe Sonya L.,Gonska Tanja,Donaldson Scott H.,Borowitz Drucy,Gelfond Daniel,Sagel Scott D.,Khan Umer,Mayer-Hamblett Nicole,Van Dalfsen Jill M.,Joseloff Elizabeth,Ramsey Bonnie W.

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference40 articles.

1. Cystic Fibrosis

2. Cystic fibrosis

3. Gastrointestinal Complications of Cystic Fibrosis

4. Sixty-five years since the New York heat wave: Advances in sweat testing for cystic fibrosis

5. Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene

Cited by 438 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The continuing need for dornase alfa for extracellular airway DNA hydrolysis in the era of CFTR modulators;Expert Review of Respiratory Medicine;2024-08-30

2. The gastrointestinal microbiome, small bowel bacterial overgrowth, and microbiome modulators in cystic fibrosis;Pediatric Pulmonology;2024-08-06

3. Impact of day-to-day variation in FEV1 on measures of change: A conceptual description;Journal of Cystic Fibrosis;2024-08

4. Association between biomarkers of tobacco smoke exposure and clinical efficacy of ivacaftor in the G551D observational trial (GOAL);Journal of Cystic Fibrosis;2024-07

5. Long-term impact of ivacaftor on mortality rate and health outcomes in people with cystic fibrosis;Thorax;2024-06-27